ALLMedicine™ CMV Retinitis Center

Mar 8th, 2022 - Valganciclovir HCl (VGH) is the widely used drug for the treatment of cytomegalovirus (CMV) retinitis infection with an induction dose of 900 mg per oral (p.o.) twice a day and a maintenance dose of 900 mg (p.o.). This required dose of the drug al...

Feb 25th, 2022 - Cytomegalovirus (CMV) retinitis is a rare end-organ disease of CMV infection and is a marker of severe immunosuppression, especially in human immunodeficiency virus (HIV)-positive patients. In multiple myeloma (MM) patients, CMV retinitis has been...

Nov 4th, 2021 - CMV is a common virus, which can cause blindness and death in AIDS patients. Previous studies demonstrate that foscarnet has been effective in both AIDS and non-AIDS patients with CMV infection. Although treatment with ganciclovir (DHPG) is also e...

Nov 3rd, 2021 - Foscarnet is active in vitro (test tube) against herpes viruses, including CMV, by inhibiting the virus DNA polymerases, enzymes necessary for virus replication, without affecting cellular DNA polymerases. Opportunistic CMV disease in AIDS is usua...

Apr 23rd, 2021 - To analyze predisposing conditions in Turkish patients with CMV retinitis and to compare HIV-positive and HIV-negative patients. We reviewed medical charts and ocular images of 41 patients with CMV retinitis diagnosed between 1996 and 2019. Eleven...

Nov 4th, 2021 - CMV is a common virus, which can cause blindness and death in AIDS patients. Previous studies demonstrate that foscarnet has been effective in both AIDS and non-AIDS patients with CMV infection. Although treatment with ganciclovir (DHPG) is also e...

Nov 3rd, 2021 - Foscarnet is active in vitro (test tube) against herpes viruses, including CMV, by inhibiting the virus DNA polymerases, enzymes necessary for virus replication, without affecting cellular DNA polymerases. Opportunistic CMV disease in AIDS is usua...

Jul 2nd, 2017 - Cytomegalovirus in solid organ transplant recipients can result in significant morbidity and mortality due to concurrent immunosuppression. Traditionally intravenous followed by oral ganciclovir has been used to prevent and treat cytomegalovirus i...

Oct 22nd, 2015 - CMV retinitis is the most common intraocular infection in patients with AIDS and is estimated to affect 35 to 40 percent of patients with AIDS. Untreated CMV retinitis is a progressive disorder, the end result of which is total retinal destruction...

Mar 1st, 2011 - Although therapy with foscarnet or ganciclovir halts retinitis progression in 90 percent of patients treated, relapses are common and may accelerate due to development of drug resistance, deteriorating immune function, or other factors. Treatment ...

Dec 20th, 2020 - Following the 2020 European Hematology Association Annual Congress, a panel of hematologic experts came together for a live Q/A session, moderated by Joerg Halter, MD, of the University Hospital Basel in Basel, Switzerland, and Stephan Mielke, MD,...

Oct 25th, 2013 - Risk of Cataract in Persons With Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome Kempen JH, Sugar EA, Lyon AT, et al Ophthalmology. 2012;119:2343-2350 Study Summary Cytomegalovirus (CMV) retinitis is the leading cause of visi...

Aug 6th, 2013 - LONDON (Reuters) - Roche is to slash the price and pool intellectual property rights on a drug to treat cytomegalovirus retinitis. The move is a further victory for the new Medicines Patent Pool (MPP), which is trying to convince major drugmakers ...

Jan 30th, 2013 - SILVER SPRING, Md. -- The FDA has approved mipomersen (Kynamro) for treating an inherited cholesterol disorder called homozygous familial hypercholesterolemia (HoFH). It's the first antisense oligonucleotide drug for systemic use to win the agency...

Aug 3rd, 2012 - August 3, 2012 — Cytomegalovirus (CMV) retinitis is associated with an increased absolute and relative risk for cataract in patients with AIDS, according to a study published online July 31 in Ophthalmology. The risk is highest for patients older ...